75806-14-3 Usage
General Description
3-Butynoic acid, 2-[(methoxycarbonyl)amino]-4-(trimethylsilyl)-, methyl ester is a chemical compound that is commonly used in organic synthesis as a building block for more complex molecules. It is a methyl ester derivative of 3-butynoic acid, which contains a terminal alkyne group and a trimethylsilyl protecting group on the amino function. 3-Butynoic acid, 2-[(methoxycarbonyl)amino]-4-(trimethylsilyl)-, methyl ester can be used as a reactant in a variety of chemical reactions, particularly in the synthesis of pharmaceuticals and fine chemicals. Its unique structure and reactivity make it a valuable intermediate in the production of diverse chemical compounds with potential applications in drugs, materials, and other fields.
Check Digit Verification of cas no
The CAS Registry Mumber 75806-14-3 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 7,5,8,0 and 6 respectively; the second part has 2 digits, 1 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 75806-14:
(7*7)+(6*5)+(5*8)+(4*0)+(3*6)+(2*1)+(1*4)=143
143 % 10 = 3
So 75806-14-3 is a valid CAS Registry Number.
InChI:InChI=1/C10H17NO4Si/c1-14-9(12)8(11-10(13)15-2)6-7-16(3,4)5/h8H,1-5H3,(H,11,13)
75806-14-3Relevant articles and documents
COMPOUNDS FOR THE TREATMENT OF INFLAMMATORY DISORDERS
-
Paragraph 0164; 0168, (2019/12/05)
This invention relates to compounds of the Formula (I)-(IX):, as defined herein, or a pharmaceutically acceptable salt, solvate or ester thereof, which can be useful for the treatment of diseases or conditions mediated by MMPs, ADAMs, TACE, aggrecanase, T
COMPOUNDS FOR THE TREATMENT OF INFLAMMATORY DISORDERS
-
Page/Page column 102-103, (2010/06/11)
This invention relates to compounds of the Formula (I): (Chemical formula should be inserted here as it appears on abstract in paper form) (I) or a pharmaceutically acceptable salt, solvate or isomer thereof, which can be useful for the treatment of diseases or conditions mediated by MMPs, ADAMs, TACE, aggrecanase, TNF- or combinations thereof.
HYDANTOIN DERIVATIVES FOR THE TREATMENT OF INFLAMMATORY DISORDERS
-
Page/Page column 140, (2008/06/13)
This invention relates to compounds of the Formula: (I); or a pharmaceutically acceptable salt, solvate or isomer thereof, which can be useful for the treatment of diseases or conditions mediated by MMPs, ADAMs, TACE, aggrecanase, TNF-α or combinations thereof.
